Filing Flows › Comparisons › PAVM vs GUTS
PAVmed vs Fractyl Health: PAVM and GUTS compared
PAVmed is the larger company: $33K of revenue in its latest quarter (Q2 2026) against $3K for Fractyl Health (Q4 2024). PAVmed is growing faster (+450% against -57% a year earlier).
Where the money goes: PAVM and GUTS
PAVmed (PAVM) · Q2 2026
PAVmed, Q2 2026: revenue $33K (+450% year over year), net loss $6.6M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
Fractyl Health (GUTS) · Q4 2024
Fractyl Health, Q4 2024: revenue $3K (-57% year over year), net loss $25.0M, operating cash flow −$17.0M. The chart follows the revenue to costs, profit and cash.
| PAVmed (PAVM) | Fractyl Health (GUTS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2024 |
| Revenue | $33K | $3K |
| Revenue growth, Y/Y | +450% | -57% |
| Operating margin | n/m | n/m |
| Net earnings | −$6.6M | −$25.0M |
| Operating cash flow | −$2.7M | −$17.0M |
Questions
Which is bigger, PAVmed or Fractyl Health?
PAVmed is the larger company: $33K of revenue in its latest quarter (Q2 2026) against $3K for Fractyl Health (Q4 2024).
Is PAVmed or Fractyl Health growing faster?
PAVmed is growing faster (+450% against -57% a year earlier).
More: PAVmed earnings · how PAVmed makes money · Fractyl Health earnings · how Fractyl Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-K filed Mar 3, 2025). Fiscal quarters can end on different dates. Not investment advice.